FdaApplication
ANDA 205781
Identifiers
- fda_app_no: ANDA205781
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2017-07-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TESTOSTERONE | TESTOSTERONE | 1.62% (40.5MG/2.5GM PACKET) | GEL;TRANSDERMAL |
| TESTOSTERONE | TESTOSTERONE | 1.62% (20.25MG/1.25GM PACKET) | GEL;TRANSDERMAL |
2 products